These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29064582)

  • 1. Establishment of a platform for molecular and immunological characterization of the RNA-dependent-RNA-polymerase NS5B of an Egyptian HCV isolate.
    Gewaid H; Mesalam AA; Ibrahim AA; Abdel Shafy DN; Abdel Shafy RN; Emara N; Hamdy SM; Gewaid M; Bahgat MM
    J Med Virol; 2018 Mar; 90(3):545-558. PubMed ID: 29064582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of NS3 protease from an Egyptian HCV genotype 4a isolate.
    Bahgat MM; Ibrahim AA; Abd-Elshafy DN; Mesalam AA; Gewaid HE; Ismaeil AA; El-Waseef AM; Maghraby AS; Barakat AB; El-Far MA; Ghanem Hel-D; Mohamed AM; Ali MA
    Arch Virol; 2009; 154(10):1649-57. PubMed ID: 19763775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo polymerase activity and oligomerization of hepatitis C virus RNA-dependent RNA-polymerases from genotypes 1 to 5.
    Clemente-Casares P; López-Jiménez AJ; Bellón-Echeverría I; Encinar JA; Martínez-Alfaro E; Pérez-Flores R; Mas A
    PLoS One; 2011 Apr; 6(4):e18515. PubMed ID: 21490973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring substitutions conferring resistance to hepatitis C virus polymerase inhibitors in treatment-naive patients infected with genotypes 1-5.
    Legrand-Abravanel F; Henquell C; Le Guillou-Guillemette H; Balan V; Mirand A; Dubois M; Lunel-Fabiani F; Payan C; Izopet J
    Antivir Ther; 2009; 14(5):723-30. PubMed ID: 19704176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of partial NS5B region among hepatitis C virus genotype 6 subtypes isolated from Thai blood donors.
    Chaiwong S; Sistayanarain A
    J Med Virol; 2016 Oct; 88(10):1785-90. PubMed ID: 27018495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of mutant NS5B proteins encoded by isolates from chimpanzees chronically infected following clonal HCV RNA inoculation.
    Lou H; Choi YH; LaVoy JE; Major ME; Hagedorn CH
    Virology; 2003 Dec; 317(1):65-72. PubMed ID: 14675625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
    Aligeti M; Roder A; Horner SM
    J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
    Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
    J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation at the N-terminal finger subdomain of a viral RNA-dependent RNA polymerase.
    Hernández S; Figueroa D; Correa S; Díaz A; Aguayo D; Villanueva RA
    Biochem Biophys Res Commun; 2015 Oct; 466(1):21-7. PubMed ID: 26301630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture.
    Cheney IW; Naim S; Lai VC; Dempsey S; Bellows D; Walker MP; Shim JH; Horscroft N; Hong Z; Zhong W
    Virology; 2002 Jun; 297(2):298-306. PubMed ID: 12083828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of B cell epitopes of hepatitis C virus RNA dependent RNA polymerase.
    Hou L; Du G; Tong Y; Wang H
    J Virol Methods; 2002 Jun; 104(1):1-8. PubMed ID: 12020787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of the hepatitis C virus NS5B gene during HIV co-infection.
    Ngwaga T; Kong L; Lin D; Schoborg C; Taylor LE; Mayer KH; Klein RS; Celentano DD; Sobel JD; Jamieson DJ; King CC; Tavis JE; Blackard JT
    PLoS One; 2020; 15(8):e0237162. PubMed ID: 32750098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.
    Jaspe RC; Sulbarán YF; Sulbarán MZ; Loureiro CL; Rangel HR; Pujol FH
    Virol J; 2012 Sep; 9():214. PubMed ID: 22995142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive structure-function comparison of hepatitis C virus strain JFH1 and J6 polymerases reveals a key residue stimulating replication in cell culture across genotypes.
    Schmitt M; Scrima N; Radujkovic D; Caillet-Saguy C; Simister PC; Friebe P; Wicht O; Klein R; Bartenschlager R; Lohmann V; Bressanelli S
    J Virol; 2011 Mar; 85(6):2565-81. PubMed ID: 21209117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus of subtype 2l in Marseille, southeastern France.
    Aherfi S; Glazunova O; Borentain P; Botta-Fridlund D; Chiche L; Bregigeon S; Motte A; Tamalet C; Colson P
    Intervirology; 2015; 58(1):6-13. PubMed ID: 25592333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
    Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
    PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
    Herlihy KJ; Graham JP; Kumpf R; Patick AK; Duggal R; Shi ST
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3523-31. PubMed ID: 18694956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of drug-resistance-associated mutations and genetic barriers in hepatitis C virus NS5B sequences in China.
    Nie B; Guo Y; Zhang K; Liu J; Yun S
    Arch Virol; 2020 Sep; 165(9):2013-2020. PubMed ID: 32601956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.